KeyBank National Association
AMRI

KeyBank National Association’s Albany Molecular Research Inc AMRI Stock Holding History

KeyBank National Association’s Portfolio AMRI Stock Details AMRI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q3 		– Sell
-38,263
Closed -$830K – 1153
2017
Q2 		$830K Buy
38,263
+3,711
+11% +$67.4K 0.01% 654
2017
Q1 		$485K Buy
34,552
+1,289
+4% +$21.1K ﹤0.01% 828
2016
Q4 		$624K Hold
33,263
– – ﹤0.01% 755
2016
Q3 		$549K Hold
33,263
– – ﹤0.01% 794
2016
Q2 		$447K Hold
33,263
– – ﹤0.01% 816
2016
Q1 		$509K Hold
33,263
– – ﹤0.01% 766
2015
Q4 		$660K Hold
33,263
– – ﹤0.01% 694
2015
Q3 		$579K Hold
33,263
– – ﹤0.01% 737
2015
Q2 		$673K Buy
33,263
+2,252
+7% +$43.5K ﹤0.01% 726
2015
Q1 		$546K Hold
31,011
– – ﹤0.01% 833
2014
Q4 		$505K Hold
31,011
– – ﹤0.01% 864
2014
Q3 		$684K Hold
31,011
– – ﹤0.01% 750
2014
Q2 		$624K Hold
31,011
– – ﹤0.01% 827
2014
Q1 		$576K Buy
31,011
+5,000
+19% +$68.8K ﹤0.01% 849
2013
Q4 		$262K Hold
26,011
– – ﹤0.01% 1121
2013
Q3 		$335K Hold
26,011
– – ﹤0.01% 1009
2013
Q2 		$309K Buy
+26,011
New +$282K ﹤0.01% 1127

Other funds holding AMRI

AA
Ancora Advisors Cleveland, Ohio $4.7B AUM 19.05% 1-Year Est. Return
DekaBank Deutsche Girozentrale
DekaBank Deutsche Girozentrale Frankfurt, Germany $60.6B AUM 23.27% 1-Year Est. Return

KeyBank National Association's AMRI Position: Q3 2017 in Review

KeyBank National Association sold out of Albany Molecular Research Inc (AMRI) in Q3 2017, closing a stake of 38,263 shares — an estimated $830K sold.

KeyBank National Association first reported a position in AMRI in Q2 2013 and held it in 17 quarters. The position peaked at $830K in Q2 2017. 2 funds tracked by Wall St. Rank hold AMRI as of Q3 2017.

  • KeyBank National Association reported no remaining Albany Molecular Research Inc position as of Q3 2017 after selling out during the quarter.
  • KeyBank National Association sold 38,263 Albany Molecular Research Inc shares in Q3 2017, an estimated $830K.
  • KeyBank National Association first reported a position in Albany Molecular Research Inc in Q2 2013 and held it in 17 quarters.
  • KeyBank National Association's Albany Molecular Research Inc position peaked at $830K in Q2 2017.
  • 2 funds tracked by Wall St. Rank held Albany Molecular Research Inc as of Q3 2017.

Based on KeyBank National Association's 13F filing for Q3 2017, filed 2 Nov 2017.